about
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...
Read More
3.02
0.20
(7.09%)
45.5M
XNAS Volume
High volume+gain today
XNAS 14 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
ImmunityBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..